Observational studyGraefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie2026
Different retinal microvascular response to flicker light between normal-tension glaucoma and high-tension primary open-angle glaucoma detected with optical coherence tomography angiography.
Observational study in Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
purposeTo compare the visual task-evoked microvascular response in the macula between normal-tension glaucoma (NTG) and high-tension primary open-angle glaucoma [i.e., high-tension glaucoma (HTG)] by using optical coherence tomography angiography (OCTA).
methodsIn this case-control observational study, ten eyes of 10 patients with HTG, twelve eyes of 12 patients with NTG and eleven eyes of 11 healthy participants were included. All glaucoma eyes had a preserved central visual field of at least 10° and best corrected visual acuity of 20/40 or better. Macular superficial vessel density (VD) was measured by OCTA at baseline and then immediately after a 12.5 Hz white light flicker stimulation.
resultsFlicker light stimulation evoked significant increase in macular superficial VD of HTG (baseline vs. poststimulation:35.31% ± 4.31% vs. 36.07% ± 4.35%, P = 0.048) and control eyes (46.21% ± 2.94% vs. 47.09% ± 2.68%, P = 0.028) but not the eyes with NTG (37.98% ± 5.99% vs. 37.44% ± 5.69%, P = 0.622). The absolute change in VD (ΔVD) was significantly smaller in NTG eyes compared to control eyes (-0.54% ± 1.40% vs. 0.88% ± 1.14%, P = 0.026). NTG eyes also had a lower VD change percentage in the temporal macula than that in HTG eyes (-1.17% ± 5.53% vs. 4.01% ± 4.73%, P = 0.042).
conclusionsVisual task-evoked vasoreactivity changes provide additional information in the understanding and assessment of the pathophysiological mechanisms of glaucoma. Discrepancies in the retinal vasoreactivity between HTG and NTG imply that vascular factors may play different roles in the onset and progression of these diseases. KEY MESSAGES: What is known Vessel density (VD) of the macular superficial retina has been proven to be reduced in individuals suffering from primary open-angle glaucoma (POAG). The reduction of VD has been found to be correlated with the progressive development of glaucoma. What is new Patients with normal-tension glaucoma (NTG) has impaired vasoreactivity to visual stimulation compared with high-tension POAG. The visual stimulation-assisted dynamic optical coherence tomography angiography (OCTA) technique can provide additional information for the vascular dysregulation in the pathophysiology of subtypes of POAG.
Indexed as
Identifiers
41123659What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.